The Larner College of Medicine has been at the vanguard of technology transfer over the past decade, supporting patents and commercialization of faculty research, which has led to several successful startups. Recent examples of commercially successful innovations by Larner faculty include Prolocor, a startup company focused on developing a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.

(MAY 10, 2023) Larner Class of 2024 medical student Dana Allison was interviewed by Medscape about presenting her research on Virtual Reality Interventions for Autistic Spectrum Disorder Therapy at the 2023 American Academy of Neurology Meeting in Boston.

(MAY 10, 2023) A federal health task force now recommends that all women with an average risk of breast cancer start screening every other year beginning at age 40 — rather than at age 50, as was recommended in the previous update in 2016, WCAX-TV reported. Brian Sprague, Ph.D., professor of surgery and biochemistry, hopes this will reverse the decline in screening that UVM Cancer Center research has shown for the past several years. “I’m hoping this will help,” he says.

(MAY 10, 2023) Natasha Withers, D.O., clinical assistant professor of family medicine, will soon start treating depression with a mind-altering drug that’s shown promise in helping people who don’t respond to traditional medicine — despite lingering questions about the drug’s long-term safety and effectiveness — Seven Days reported.